Holen Sie sich die Stockscreener-App
6.89
0.86%
-0.06
Handel nachbörslich:
7.02
0.13
+1.89%
Treace Medical Concepts Inc Aktie (TMCI) Neueste Nachrichten
Treace Medical Concepts: Positive Q2 Earnings Call Highlights - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Investors to Inquire about Securities Investigation - ACCESS Newswire
Treace Medical Concepts (NASDAQ:TMCI) Releases Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Arcadia Wealth Management Inc. Takes Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Stifel Nicolaus Lowers Treace Medical Concepts (NASDAQ:TMCI) Price Target to $6.00 - MarketBeat
Investigation announced for Investors who hold shares of Treace - openPR.com
SEC Filings Archive 2025-08-12Historical 10-K, 10-Q, 8-K Forms - Stock Titan
UBS Group Has Lowered Expectations for Treace Medical Concepts (NASDAQ:TMCI) Stock Price - MarketBeat
Is Treace Medical Concepts Inc. stock ready for a breakoutHigh Reward Picks with Tight Risk Control - Newser
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Reach Out - ACCESS Newswire
Treace Medical anticipates 7–10% revenue growth in 2025 while launching next-gen bunion solutions - MSN
Key metrics from Treace Medical Concepts Inc.’s quarterly dataWeekly Entry Signal Based Forecast Tool - Newser
Analysts Have Been Trimming Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Price Target After Its Latest Report - Yahoo Finance
Insider Stock Buying Reaches US$1.80m On Treace Medical Concepts - 富途牛牛
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported, And Analysts Assigned A US$8.35 Price Target - simplywall.st
Evaluating Treace Medical Concepts Inc. with trendline analysisMarket Sentiment Tracker with Smart Alerts - Newser
UBS Group Reaffirms Neutral Rating for Treace Medical Concepts (NASDAQ:TMCI) - Defense World
How to manage a losing position in Treace Medical Concepts Inc.Market Liquidity and Price Flow Analysis - Newser
Why did TMCI's Q4 2024 EPS surprise investors? - AInvest
Health Check: How Prudently Does Treace Medical Concepts (NASDAQ:TMCI) Use Debt? - simplywall.st
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q2 2025 Earnings Call Transcript - Insider Monkey
Treace Medical Concepts Maintains Buy Rating with $12 Price Target: Analyst - AInvest
Treace Medical Concepts Inc (TMCI) Q2 2025 Earnings Call Highlights: Revenue Growth and ... By GuruFocus - Investing.com Canada
Treace Medical Concepts Trims Losses As Revenue Rises - Finimize
Treace Medical Concepts revenue up 7% to USD 47.4M in Q2 2025 - Medical Buyer
Treace Medical Concepts Reports Q2 2025 Financial Results - TipRanks
Treace Medical Concepts Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Treace Medical (TMCI) Q2 Revenue Up 7% - The Motley Fool
Treace Medical Concepts, Inc. shares rise 3.35% after-hours after Q2 revenue beats estimates. - AInvest
Treace Medical Concepts: Q2 Earnings Snapshot - San Antonio Express-News
Treace Medical Concepts (TMCI) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Treace Medical Concepts Reports Second Quarter 2025 Financial Results - The Manila Times
Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025 - The Manila Times
Treace Medical to Showcase Revolutionary Bunion Surgery Innovations at Upcoming Investor Day - Stock Titan
Treace Medical Concepts, Inc. shares fall 1.25% intraday after publishing positive four-year interim results from its ALIGN3D study. - AInvest
Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Inve - GlobeNewswire
Treace Announces Peer-Reviewed Publication of Four-Year Results of the ALIGN3D™ Lapiplasty® Multicenter Prospective Clinical Study - The Manila Times
Revolutionary Bunion Surgery Success: New 4-Year Study Reveals 99.2% Non-Recurrence Rate for Lapiplasty - Stock Titan
Important Notice to Long-Term Shareholders of Centene - GlobeNewswire
GSA Capital Partners LLP Buys New Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Analyzing Treace Medical Concepts Inc. with risk reward ratio chartsStock Market Watch with Smart Filters - Newser
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.52 Average PT from Analysts - MarketBeat
How to interpret RSI for Treace Medical Concepts Inc. stockConservative Equity Setup with Signal Analysis - Newser
What catalysts could drive Treace Medical Concepts Inc. stock higher in 2025Invest like a pro with expert recommendations - Jammu Links News
What drives Treace Medical Concepts Inc. stock priceUnlock powerful trading techniques - Jammu Links News
What is the risk reward ratio of investing in Treace Medical Concepts Inc. stockUnmatched market performance - Jammu Links News
How many analysts rate Treace Medical Concepts Inc. as a “Buy”Exceptional profit potential - Jammu Links News
1.74%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):